Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon-Reference-Cited by-同舟云学术

Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon

Published:2018-03-05 Issue:2 Volume:7 Page:147-161
ISSN:2162-4968
Container-title:Current Obesity Reports
language:en
Short-container-title:Curr Obes Rep

Author:

Srivastava Gitanjali,Apovian Caroline

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/article/10.1007/s13679-018-0300-4/fulltext.html

Reference136 articles.

1. Gregg EW, Shaw JE. Global health effects of overweight and obesity. N Engl J Med. 2017;377:80–1. https://doi.org/10.1056/NEJMe1706095 .

2. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–91. https://doi.org/10.1001/jama.2016.6458 .

3. •• Apovian CM, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342–62. https://doi.org/10.1210/jc.2014-3415 . Provides current guidelines for clinical application of approved anti-obesity drugs.

4. Van Gaal LF, Broom JI, Enzi G, Toplak H. Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group. Eur J Clin Pharmacol. 1998;54:125–32.

5. James WP, Avenell A, Broom J, Whitehead J. A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord. 1997;21(Suppl 3):S24–30.

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring monocyclic core: Discovery of pyrrol-2-one derivatives as a new series of potent MCHR1 antagonists with in vivo efficacy;European Journal of Medicinal Chemistry;2024-10

2. POTENTIAL ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS IN SUBSTANCE USE DISORDER: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS;Drug and Alcohol Dependence;2024-09

3. The Interplay between Obesity and Inflammation;Life;2024-07-08

4. Neuroinflammation induced by amyloid-forming pancreatic amylin: Rationale for a mechanistic hypothesis;Biophysical Chemistry;2024-07

5. A 12-Week, Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial for the Evaluation of the Efficacy and Safety of Lactiplantibacillus plantarum SKO-001 in Reducing Body Fat;Nutrients;2024-04-11